Roya Raeisi Jaski

Roya Raeisi Jaski

Auto-generated profile, based on publicly available information

Roya Raeisi Jaski

Student Research Committee, Rajaei Cardiovascular, Medical, and Research Center, Tehran, Iran

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2024 in Journal of Renal Injury Prevention
Verified
Journal Article
Open access
RHRamin Haghighi
Ramin Haghighi
NSNasim Zaman Samghabadi
Nasim Zaman Samghabadi
RJRoya Raeisi Jaski
Roya Raeisi Jaski
SRSonia Razmjou
Sonia Razmjou
AHAlireza Habibzadeh
Alireza Habibzadeh
ZTZahra Tavassoli
Zahra Tavassoli
Introduction: Sodium-glucose transporter 2 (SGLT-2) inhibitors induce glycosuria. Therefore, using a meta-analysis study, this study aimed to evaluate the correlation between SGLT2 inhibitor administration and urinary tract infection (UTI) risk. Materials and Methods: In this systematic review and meta-analysis, we conducted searches on Scopus, PubMed, Web of Science, Cochrane, and Google Scholar without time limitations up to October 16, 2023. Data were analyzed using STATA 14 software, and a significance level of P < 0.05 was considered. Results: The combination of 11 studies revealed that the use of SGLT2 inhibitors, when compared to glucagon-like peptide-1 (GLP-1) receptor agonists, reduced the risk of UTI (OR = 0.77; 95% CI: 0.62, 0.95) and when compared to insulin (OR = 0.74; 95% CI: 0.63, 0.87). However, the administration of SGLT2 inhibitors, when compared to dipeptidyl peptidase‐4 (DPP‐4) inhibitors (OR = 1.09; 95% CI: 0.90, 1.32), sulfonylureas (OR = 1.35; 95% CI: 0.88, 2.05), biguanide initiators (OR = 1.14; 95% CI: 1.05, 1.24), thiazolidinediones (OR = 1.19; 95% CI: 0.58, 2.44), and other antidiabetic drugs (OR = 1.20; 95% CI: 0.92, 1.57), did not increase the risk of UTI. The administration of dapagliflozin (OR = 1.51; 95% CI: 0.60, 3.81), canagliflozin (OR = 1.22; 95% CI: 0.47, 3.15), and empagliflozin (OR = 3.22; 95% CI: 2.97, 3.48) showed associations with UTI risk. Furthermore, the correlation between SGLT2 inhibitors use and UTI risk was observed in cohort studies (OR = 1.14; 95% CI: 0.98, 1.32), cross-sectional studies (OR = 0.86; 95% CI: 0.64, 1.14), in males (OR = 1; 95% CI: 0.72, 1.40), and females (OR = 1.17; 95% CI: 0.91, 1.52). Conclusion: Empagliflozin, in contrast to dapagliflozin and canagliflozin, increases the risk of UTI. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO (CRD42023479548) and Research Registry (UIN: reviewregistry1742) Websites

4 April 2024 in Journal of Preventive Epidemiology
Verified
Journal Article
Open access
BTBanafsheh Tehranineshat
Banafsheh Tehranineshat
NSNasim Zaman Samghabadi
Nasim Zaman Samghabadi
ZSZahra Shahryarpanah
Zahra Shahryarpanah
ZEZahra Eydizadeh
Zahra Eydizadeh
RJRoya Raeisi Jaski
Roya Raeisi Jaski
NPNajmeh Parsai
Najmeh Parsai
Introduction: Surgery cancellation causes complications such as disrupting the daily schedule of surgery in the operating room, delays in patient care, and potential financial losses for the hospital or surgical center. Objectives: This study aimed to investigate the prevalence and causes of gynecological surgery cancellations at Shariati Bandar Abbas hospital. Patients and Methods: This descriptive-analytical study was conducted on 212 patients in the Shariati hospital of Bandar Abbas, Iran, from April to November 2023. Data were collected through a demographic questionnaire and a researcher-made checklist, including clinical data. To analyze data SPSS version 27 and analytical tests were used. Results: Out of 212 studied patients, the surgery for 67 was canceled, resulting in a surgery canceling prevalence rate of 31.6%. Surgery type, age, history of diabetes mellitus, thyroid disease, and other diseases were not risk factors for surgery cancelation (P>0.05); however, cardiovascular disease history, not being nil per os (NPO), and not having surgery consent were independent risk factors (P<0.05). Conclusion: In conclusion, the high prevalence of surgery cancellations in Iran’s educational hospitals necessitates a comprehensive and systematic investigation of the factors involved, including patient evaluation, anesthesiologist approval, patient readiness, and the impact on patients’ overall health and well-being.

28 March 2026 in Immunopathologia Persa
Verified
Journal Article
Closed access
ZKZahed Karimi
Zahed Karimi
SNSara Abutalebi Nasrabad
Sara Abutalebi Nasrabad
RFReza Farzaneh
Reza Farzaneh
SBSeyed Amir Banikarim
Seyed Amir Banikarim
FSFarkhondeh Sameipoor
Farkhondeh Sameipoor
NNNaeem Nikpour
Naeem Nikpour
The mechanistic sequence from hyperandrogenism to tumorigenesis in women with polycystic ovary syndrome (PCOS) encompasses a constellation of structural and functional aberrations spanning the endocrine, metabolic, immunologic, and genetic domains. Chronic hyperandrogenism incites an interconnected cascade through chronic anovulation and unopposed estrogen action, insulin resistance with hyperinsulinemia, low-grade systemic inflammation, oxidative stress, and gut dysbiosis, each playing a synergistic role in promoting oncogenesis. It has been demonstrated that, this syndrome is most strongly associated with an increased risk of endometrial cancer, with a more modest and less consistent association with ovarian and breast cancers. Thyroid cancer risk may also be elevated, particularly in younger women. The underlying mechanisms involve hormonal imbalances, metabolic dysfunction, chronic inflammation, and genetic predisposition. Women with PCOS should be monitored for early signs of these cancers, and management should focus on mitigating risk factors such as obesity, insulin resistance, and chronic anovulation.